Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 5, Pages e1426516
Publisher
Informa UK Limited
Online
2018-01-15
DOI
10.1080/2162402x.2018.1426516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein
- (2017) Yulei Chen et al. Journal of Hematology & Oncology
- Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells
- (2017) Ippei Miyagawa et al. JOURNAL OF IMMUNOLOGY
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples
- (2017) Guanzhang Li et al. OncoImmunology
- Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms
- (2016) J. M. Lykken et al. BLOOD
- CGCG clinical practice guidelines for the management of adult diffuse gliomas
- (2016) Tao Jiang et al. CANCER LETTERS
- Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies
- (2016) Lynette M Phillips et al. JOURNAL OF PATHOLOGY
- Interaction between ANXA1 and GATA-3 in Immunosuppression of CD4+ T Cells
- (2016) Peng Huang et al. MEDIATORS OF INFLAMMATION
- Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer
- (2016) Guangcun Cheng et al. Molecular Cancer
- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013
- (2016) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
- (2016) A. Sobo-Vujanovic et al. Cancer Immunology Research
- Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
- (2016) Zheng Wang et al. OncoImmunology
- Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions
- (2015) Julia Kravchenko et al. CARCINOGENESIS
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Identification of a 6-Cytokine Prognostic Signature in Patients with Primary Glioblastoma Harboring M2 Microglia/Macrophage Phenotype Relevance
- (2015) Jinquan Cai et al. PLoS One
- circlize implements and enhances circular visualization in R
- (2014) Zuguang Gu et al. BIOINFORMATICS
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
- (2014) G. J. Baker et al. CANCER RESEARCH
- Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice
- (2014) Bastian Seubert et al. HEPATOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
- (2013) T. Doucette et al. Cancer Immunology Research
- VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
- (2013) Magali Terme et al. OncoImmunology
- Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies
- (2012) Y. Li et al. ANNALS OF ONCOLOGY
- Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors
- (2012) A. M. Donson et al. JOURNAL OF IMMUNOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF- B network
- (2012) K. M. Holmes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoplastic “Black Ops”: Cancer's subversive tactics in overcoming host defenses
- (2012) Arya Biragyn et al. SEMINARS IN CANCER BIOLOGY
- IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
- (2011) John B. Mumm et al. CANCER CELL
- Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
- (2011) A. Banh et al. CANCER RESEARCH
- Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
- (2011) Christopher Jackson et al. Clinical & Developmental Immunology
- Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties
- (2011) Jennifer C. Rodrigues et al. NEURO-ONCOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
- (2010) N. Demotte et al. CANCER RESEARCH
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Annexin A1 regulates TGF- signaling and promotes metastasis formation of basal-like breast cancer cells
- (2010) M. de Graauw et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- Epigenetic regulation of the alternatively activated macrophage phenotype
- (2009) M. Ishii et al. BLOOD
- IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas
- (2009) L. M. Moore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin-like Growth Factor-Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer
- (2008) K. H. Park et al. CANCER RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More